Improvement in clinical outcomes of type 2 diabetic patients after pharmacist-physician collaborative care for dyslipidemia

Background and aim: The rising prevalence of type 2diabetes poses a major public health challenge. Studies have clearly shown that long-term outcomes for patients with type 2 diabetes can be improved with careful management aimed at controlling glucose, lipid and blood pressure levels. The aim of the study was to evaluate the impact of pharmacist-physician collaborative care for management of dyslipidemia on QOL of type2 diabetic patients. Methods: This study included 40 diabetic dyslipidemic patients divided into: 20 who received pharmacist-physician collaborative care for management of dyslipidemia as group A and 20 who received the usual medical care by physician only as group B. They were subjected to full clinical history, HbA1c, TC, TG, HDL-c , LDL-c at baseline and after 3 & 6 months also QOL was assessed by SF-36 questionnaire at baseline and after 6 months. Results : There was a highly significant ( p value < 0.001) improvement in levels of HbA1c,TC, TG, HDL-c, and LDL-c in patients in group A after 6 months of the study than compared to group B. There was an increase in number of patients who reached HbA1c goal and lipid profile goal after 6 months of group A than in group B. There was significant difference in QOL scores of questionnaire in group A than in group B after 6 months of the study and also there was significant difference in the scores in group A after 6 months than baseline scores, p-value < 0.05. Conclusion: clinical pharmacist-physician collaborative care leads to improvement in management of dyslipidemia in diabetic patients than those who receive the usual medical care.